EXPLANATORY NOTE
This Schedule 13D (the “Schedule 13D”) is being filed by The Heritage Group, a general partnership formed under the laws of the State of Indiana (the “Reporting Person”), and relates to the common stock, par value $0.01 per share (the “Common Stock”), of Calumet, Inc., a Delaware corporation (the “Issuer” or “New Calumet”).
The Schedule 13D also serves to amend and supplement the Schedule 13D that was filed by the Reporting Person with the Securities and Exchange Commission on May 9, 2008 and amended on May 20, 2008, May 23, 2008, March 3, 2009, February 22, 2011, May 22, 2018 and April 18, 2019 (File No. 005-81723; Accession No: 0000908834-09-000094) (as amended thereby, the “Original Schedule 13D”). From and after the date hereof, all references in the Original Schedule 13D to the Schedule 13D or terms of similar import shall be deemed to refer to the Original Schedule 13D as amended and supplemented hereby.
Capitalized terms used herein and not otherwise defined shall have the respective meanings ascribed to them in the Original Schedule 13D. Except as set forth herein, the Original Schedule 13D is unmodified.
Item 1. | Security and Issuer |
Calumet Specialty Products Partners, L.P., a Delaware limited partnership (the “Partnership”), entered into that certain Partnership Restructuring Agreement, dated November 9, 2023, among the Partnership, Calumet GP, LLC (the “General Partner”) and the other parties thereto, including the Reporting Person (collectively, the “Sponsor Parties”), as amended by the First Amendment to the Partnership Restructuring Agreement, dated February 9, 2024 (as amended, the “Restructuring Agreement”), in order to effectuate a corporate conversion of the Partnership from a master limited partnership to a Delaware corporation (the “Conversion”), subject to the terms and conditions set forth in the Restructuring Agreement.
The Partnership also entered into that certain Conversion Agreement, dated February 9, 2024, among the Partnership, the General Partner, New Calumet, Calumet Merger Sub I LLC (“Merger Sub I”), Calumet Merger Sub II LLC (“Merger Sub II” and, together with Merger Sub I, the “Merger Subs”) and the Sponsor Parties, as amended by the First Amendment to the Conversion Agreement, dated April 17, 2024 (as amended, the “Conversion Agreement”).
On July 10, 204, pursuant to the Conversion Agreement, (i) Merger Sub II, a wholly owned subsidiary of New Calumet, merged with and into the Partnership, with the Partnership continuing as the surviving entity and a wholly owned subsidiary of New Calumet, pursuant to which all of the common units representing limited partner interests in the Partnership (“common units”) were exchanged into the right to receive an equal number of shares of Common Stock (the “Partnership Merger”); and (ii) immediately after the Partnership Merger, Merger Sub I, a wholly owned subsidiary of New Calumet, merged with and into the General Partner, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of New Calumet, pursuant to which all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Common Stock and 2,000,000 warrants (the “Warrants”) to purchase Common Stock at an exercise price of $20.00 per share (subject to adjustment) (the “GP Merger” and, together with the Partnership Merger, the “Mergers”; the Mergers together with the Conversion, the “Transactions”).
The foregoing descriptions of the Conversion Agreement and the Restructuring Agreement and the transactions contemplated thereby do not purport to be complete and are qualified in their entirety by the actual Conversion Agreement and Restructuring Agreement, copies of which are filed as Exhibits B, C, D, E hereto and are incorporated by reference in their entirety to this Item 4.
The Issuer is the successor issuer to the Partnership pursuant to Rule 12g-3(a) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Therefore, this Schedule 13D relates to the Issuer’s shares of Common Stock. The principal executive offices of the Issuer are located at 2780 Waterfront Parkway East Drive, Suite 200, Indianapolis, Indiana 46214, and its telephone number is (317) 328-5660.
3